119 related articles for article (PubMed ID: 37244789)
1. VEPH1 suppresses the progression of gastric cancer by regulating the Hippo-YAP signalling pathway.
Nie X; Zhou Z; Chen Y; Chen S; Chen Y; Lei J; Wu X; He S
Dig Liver Dis; 2024 Jan; 56(1):187-197. PubMed ID: 37244789
[TBL] [Abstract][Full Text] [Related]
2. Overexpressed VEPH1 inhibits epithelial-mesenchymal transition, invasion, and migration of human cutaneous melanoma cells through inactivating the TGF-β signaling pathway.
Feng H; Jia XM; Gao NN; Tang H; Huang W; Ning N
Cell Cycle; 2019 Nov; 18(21):2860-2875. PubMed ID: 31599708
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA HCG18 up-regulates the expression of WIPF1 and YAP/TAZ by inhibiting miR-141-3p in gastric cancer.
Liu Y; Lin W; Dong Y; Li X; Lin Z; Jia J; Zou W; Pan Y
Cancer Med; 2020 Sep; 9(18):6752-6765. PubMed ID: 32725768
[TBL] [Abstract][Full Text] [Related]
4. Dampened VEPH1 activates mTORC1 signaling by weakening the TSC1/TSC2 association in hepatocellular carcinoma.
Dong P; Wang X; Liu L; Tang W; Ma L; Zeng W; Sun S; Zhang L; Zhang N; Shen X; Janssen HLA; Dong L; Zhang S; Chen S
J Hepatol; 2020 Dec; 73(6):1446-1459. PubMed ID: 32610114
[TBL] [Abstract][Full Text] [Related]
5. PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway.
Fujimoto D; Ueda Y; Hirono Y; Goi T; Yamaguchi A
Oncotarget; 2015 Oct; 6(33):34788-99. PubMed ID: 26431277
[TBL] [Abstract][Full Text] [Related]
6. NUPR1 participates in YAP-mediate gastric cancer malignancy and drug resistance via AKT and p21 activation.
Jiang L; Wang W; Li Z; Zhao Y; Qin Z
J Pharm Pharmacol; 2021 Apr; 73(6):740-748. PubMed ID: 33793788
[TBL] [Abstract][Full Text] [Related]
7. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
[TBL] [Abstract][Full Text] [Related]
8. CBX2 depletion inhibits the proliferation, invasion and migration of gastric cancer cells by inactivating the YAP/β-catenin pathway.
Zeng M; Li B; Yang L; Guan Q
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33313949
[TBL] [Abstract][Full Text] [Related]
9. Nonreceptor tyrosine phosphatase 14 promotes proliferation and migration through regulating phosphorylation of YAP of Hippo signaling pathway in gastric cancer cells.
Han X; Sun T; Hong J; Wei R; Dong Y; Huang D; Chen J; Ren X; Zhou H; Tian W; Jia Y
J Cell Biochem; 2019 Oct; 120(10):17723-17730. PubMed ID: 31168824
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA miR-23b-3p promotes osteosarcoma by targeting ventricular zone expressed PH domain-containing 1 (VEPH1)/phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) pathway.
Fan L; Cao X; Lei Y
Bioengineered; 2021 Dec; 12(2):12568-12582. PubMed ID: 34903122
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
[No Abstract] [Full Text] [Related]
12. CHRDL2 promotes cell proliferation by activating the YAP/TAZ signaling pathway in gastric cancer.
Wang L; Xu W; Mei Y; Wang X; Liu W; Zhu Z; Ni Z
Free Radic Biol Med; 2022 Nov; 193(Pt 1):158-170. PubMed ID: 36206931
[TBL] [Abstract][Full Text] [Related]
13. Acacetin inhibits invasion, migration and TGF-β1-induced EMT of gastric cancer cells through the PI3K/Akt/Snail pathway.
Zhang G; Li Z; Dong J; Zhou W; Zhang Z; Que Z; Zhu X; Xu Y; Cao N; Zhao A
BMC Complement Med Ther; 2022 Jan; 22(1):10. PubMed ID: 35000605
[TBL] [Abstract][Full Text] [Related]
14. VEPH1 expression decreases vascularisation in ovarian cancer xenografts and inhibits VEGFA and IL8 expression through inhibition of AKT activation.
Shathasivam P; Kollara A; Spybey T; Park S; Clarke B; Ringuette MJ; Brown TJ
Br J Cancer; 2017 Apr; 116(8):1065-1076. PubMed ID: 28301874
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of YAP inhibits growth in Hep-2 laryngeal cancer cells via epithelial-mesenchymal transition and the Wnt/β-catenin pathway.
Tang X; Sun Y; Wan G; Sun J; Sun J; Pan C
BMC Cancer; 2019 Jul; 19(1):654. PubMed ID: 31269911
[TBL] [Abstract][Full Text] [Related]
16. Netrin-1 promotes metastasis of gastric cancer by regulating YAP activity.
Yin K; Dang S; Cui L; Fan X; Wang L; Xie R; Qu J; Shang M; Chen J; Xu Z
Biochem Biophys Res Commun; 2018 Jan; 496(1):76-82. PubMed ID: 29305865
[TBL] [Abstract][Full Text] [Related]
17. Ventricular Zone Expressed PH Domain Containing 1 (VEPH1): an adaptor protein capable of modulating multiple signaling transduction pathways during normal and pathological development.
Brown TJ; Kollara A; Shathasivam P; Ringuette MJ
Cell Commun Signal; 2019 Sep; 17(1):116. PubMed ID: 31500637
[TBL] [Abstract][Full Text] [Related]
18. MCM6 is a critical transcriptional target of YAP to promote gastric tumorigenesis and serves as a therapeutic target.
Wang Y; Chen H; Liu W; Yan H; Zhang Y; Cheung AHK; Zhang J; Chen B; Liang L; Zhou Z; Wong CC; Wu WKK; Chan MWY; Cheng ASL; Ma BBY; Yu J; Lo KW; To KF; Kang W
Theranostics; 2022; 12(15):6509-6526. PubMed ID: 36185598
[No Abstract] [Full Text] [Related]
19. Downregulation of NUSAP1 suppresses cell proliferation, migration, and invasion via inhibiting mTORC1 signalling pathway in gastric cancer.
Ge Y; Li Q; Lin L; Jiang M; Shi L; Wang B; Yang L; Xu Z
Cell Biochem Funct; 2020 Jan; 38(1):28-37. PubMed ID: 31710389
[TBL] [Abstract][Full Text] [Related]
20. LKB1 inhibits the proliferation of gastric cancer cells by suppressing the nuclear translocation of Yap and β-catenin.
Ma LG; Bian SB; Cui JX; Xi HQ; Zhang KC; Qin HZ; Zhu XM; Chen L
Int J Mol Med; 2016 Apr; 37(4):1039-48. PubMed ID: 26936013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
